Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,180
Closed -$251K 280
2025
Q4
$251K Sell
3,180
-100
-3% -$7.92K ﹤0.01% 248
2025
Q3
$270K Sell
3,280
-217
-6% -$17.1K ﹤0.01% 248
2025
Q2
$281K Buy
3,497
+182
+5% +$14K 0.01% 237
2025
Q1
$266K Buy
3,315
+167
+5% +$13.9K 0.01% 249
2024
Q4
$258K Buy
3,148
+127
+4% +$10.6K 0.01% 246
2024
Q3
$249K Buy
3,021
+39
+1% +$2.91K ﹤0.01% 252
2024
Q2
$209K Buy
+2,982
New +$213K ﹤0.01% 266
2022
Q3
Sell
-4,004
Closed -$251K 268
2022
Q2
$251K Buy
4,004
+72
+2% +$4.77K 0.01% 238
2022
Q1
$276K Buy
+3,932
New +$266K 0.01% 238

Other funds holding MET

R.M. Davis Inc's MET Position: Q1 2026 in Review

R.M. Davis Inc sold out of MetLife (MET) in Q1 2026, closing a stake of 3,180 shares — an estimated $251K sold.

R.M. Davis Inc first reported a position in MET in Q1 2022 and held it in 9 quarters. The position peaked at $281K in Q2 2025. 1,382 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • R.M. Davis Inc reported no remaining MetLife position as of Q1 2026 after selling out during the quarter.
  • R.M. Davis Inc sold 3,180 MetLife shares in Q1 2026, an estimated $251K.
  • R.M. Davis Inc first reported a position in MetLife in Q1 2022 and held it in 9 quarters.
  • R.M. Davis Inc's MetLife position peaked at $281K in Q2 2025.
  • 1,382 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on R.M. Davis Inc's 13F filing for Q1 2026, filed 13 May 2026.